A. Sowunmi et Amj. Oduola, VIABILITY OF PLASMODIUM-FALCIPARUM EX-VIVO - COMPARISON OF THE EFFECTS OF ARTEMETHER AND SULFADOXINE-PYRIMETHAMINE, European Journal of Clinical Pharmacology, 54(3), 1998, pp. 221-226
Objective: Severe malaria is increasingly treated with artemether and
sulfadoxine-pyrimethamine, but their effects on the viability of Plasm
odium falciparum ex vivo following therapeutic doses, and the relation
ship between conventional indices of therapeutic response and parasite
viability, have not been evaluated. We assessed these parameters in c
hildren with severe non-cerebral falciparum malaria. Methods: Between
May and August 1995, 17 children with severe non-cerebral malaria were
randomized to receive therapeutic doses of artemether or sulfadoxine-
pyrimethamine. Parasitemia quantification and withdrawal of blood cult
ure of P. falciparum in vitro were done before and at specific interva
ls after drug administration. Therapeutic indices of response were det
ermined by the conventional method. The corresponding viability estima
tes ex vivo were derived for each drug and compared with conventional
therapeutic indices. Results: Artemether produced a significantly more
rapid reduction of parasitemia and fever than sulfadoxine-pyrimethami
ne. Resistance to sulfadoxine-pyrimethamine was present in three out o
f seven patients (RI, RII and RIII) and was readily detectable by the
functional viability estimate ex vivo. Ex vivo, functional reduction o
f parasite viability was significant 8 or 12 h after administration of
artemether, with no functionally viable parasites 30 h after administ
ration. In contrast, functional viability in isolates sensitive to sul
fadoxine-pyrimethamine became significant by 16-20 h after drug admini
stration and viable parasites were still evident after 36 h in some is
olates. Indices of therapeutic response estimated by the conventional
methods, i.e., time to 50% or 90% reduction of parasitemia and parasit
e clearance time, were significantly higher than those derived from th
e corresponding functional viability estimates ex vivo for each drug.
There was correlation between some of the two sets of parameters. Conc
lusions: These data suggest the rapid and relatively broad stage effec
ts of artemether when compared with sulfadoxine-pyrimethamine on P. fa
lciparum asexual forms. Estimation of parasite viability indices ex vi
vo permits comparison of the relative speed of antimalarial drug actio
n.